Villere ST Denis J & Co LLC holds a diversified book of 85 stocks worth $837.8M as of Q2 2026 (disclosed Aug 7, 2026, a ~38-day 13F lag). This quarter they opened Schwab US Large-Cap Growth and trimmed Ligand Pharmaceuticals. Their largest long position is Ligand Pharmaceuticals at 6% of the equity book.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
94% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Other tracked managers holding the same core names as Villere ST Denis J & Co LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| ROYAL BANK OF CANADA | 79 / 80 | $132.5B |
| FMR LLC | 78 / 80 | $614.9B |
| MORGAN STANLEY | 78 / 80 | $469.2B |
| JPMORGAN CHASE & CO | 78 / 80 | $411.3B |
| BANK OF AMERICA CORP /DE/ | 78 / 80 | $319.3B |
| UBS Group AG | 78 / 80 | $120.8B |
| OSAIC HOLDINGS, INC. | 78 / 80 | $14.4B |
| Allworth Financial LP | 78 / 80 | $6.9B |
Ranked by how many of Villere ST Denis J & Co LLC's top 80 disclosed names each fund also holds: a cross-fund conviction signal from the latest 13F of every tracked manager.
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Ligand Pharmaceuticals Inc COM NEW | $49.2M | 155.5K | 5.9% | ▼−18% Reduced · −33K sh | |
| 2 | JPMorgan Chase & Co COM | $38.3M | 116.9K | 4.6% | ▼−8.8% Reduced · −11K sh | |
| 3 | Visa Inc COM CL A | $34.3M | 99.9K | 4.1% | ▼−14% Reduced · −16K sh | |
| 4 | Amazon Com Inc COM | $32.6M | 136.9K | 3.9% | ▼−13% Reduced · −20K sh | |
| 5 | Chevron Corporation COM | $29.8M | 179.9K | 3.6% | ▼−7.8% Reduced · −15K sh | |
| 6 | Apple Inc COM | $28.3M | 97.9K | 3.4% | ▼−6.8% Reduced · −7K sh | |
| 7 | Palomar Hldgs Inc COM | $27.3M | 216.3K | 3.3% | ▼−12% Reduced · −30K sh | |
| 8 | Johnson & Johnson COM | $27.1M | 106.8K | 3.2% | ▼−12% Reduced · −15K sh | |
| 9 | Lineage Inc COM | $26.7M | 618.5K | 3.2% | ▼−13% Reduced · −89K sh | |
| 10 | Freeport McMoran Inc CL B | $26.7M | 424.4K | 3.2% | ▼−11% Reduced · −50K sh | |
| 11 | Lockheed Martin Corp COM | $25.5M | 50.0K | 3.0% | ▼−8.1% Reduced · −4K sh | |
| 12 | Atlas Energy Solutions Inc COM NEW | $22.4M | 1.35M | 2.7% | ▼−27% Reduced · −507K sh | |
| 13 | On Semiconductor Corp COM | $22.3M | 235.9K | 2.7% | ▼−32% Reduced · −109K sh | |
| 14 | First Intst Bancsystem Inc COM | $21.9M | 567.7K | 2.6% | ▼−9.5% Reduced · −59K sh | |
| 15 | Pool Corp COM | $20.9M | 97.0K | 2.5% | ▼−17% Reduced · −20K sh | |
| 16 | Bank Of Amer Corp 7.25%CNV PFD L | $20.7M | 16.5K | 2.5% | ▼−11% Reduced · −2K sh | |
| 17 | On Hldg AG NAMEN AKT A | $20.7M | 583.2K | 2.5% | ▼−5.3% Reduced · −33K sh | |
| 18 | Steris PLC SHS USD | $20.6M | 98.0K | 2.5% | ▼−9.9% Reduced · −11K sh | |
| 19 | Stryker Corporation COM | $20.3M | 64.5K | 2.4% | ▼−14% Reduced · −11K sh | |
| 20 | Abbott Laboratories COM | $18.9M | 208.8K | 2.3% | ▼−9.4% Reduced · −22K sh | |
| 21 | Microchip Technology Inc. COM | $17.9M | 196.5K | 2.1% | ▼−42% Reduced · −143K sh | |
| 22 | Idexx Labs Inc COM | $17.8M | 33.7K | 2.1% | ▼−13% Reduced · −5K sh | |
| 23 | Colgate Palmolive Co COM | $17.7M | 193.2K | 2.1% | ▼−15% Reduced · −35K sh | |
| 24 | Roper Technologies Inc COM | $17.6M | 51.9K | 2.1% | ▼−10% Reduced · −6K sh | |
| 25 | Progressive Corp COM | $17.4M | 79.8K | 2.1% | ▼−8.9% Reduced · −8K sh | |
| 26 | Verizon Communications Inc COM | $17.3M | 409.0K | 2.1% | ▼−12% Reduced · −56K sh | |
| 27 | Pepsico Inc COM | $16.9M | 124.5K | 2.0% | ▼−10.0% Reduced · −14K sh | |
| 28 | Tidewater Inc New COM | $16.6M | 249.9K | 2.0% | ▼−15% Reduced · −43K sh | |
| 29 | Option Care Health Inc COM NEW | $16.4M | 780.3K | 2.0% | ▼−2.6% Reduced · −21K sh | |
| 30 | Microsoft Corp COM | $16.3M | 43.7K | 1.9% | ▼−9.2% Reduced · −4K sh | |
| 31 | Uber Technologies Inc COM | $16.1M | 223.1K | 1.9% | ▼−15% Reduced · −40K sh | |
| 32 | Mondelez Intl Inc CL A | $16.0M | 277.1K | 1.9% | ▼−12% Reduced · −37K sh | |
| 33 | Republic Svcs Inc COM | $15.3M | 71.8K | 1.8% | ▼−5.1% Reduced · −4K sh | |
| 34 | United Parcel Svcs Inc CL B | $15.0M | 139.9K | 1.8% | ▼−11% Reduced · −17K sh | |
| 35 | Pfizer Inc COM | $12.9M | 536.4K | 1.5% | ▼−6.7% Reduced · −39K sh | |
| 36 | Kenvue Inc COM | $12.4M | 650.5K | 1.5% | ▼−12% Reduced · −93K sh | |
| 37 | Schwab Strategic TR US LCAP GR ETF | $8.4M | 247.0K | 1.0% | ▲New New position | |
| 38 | Schwab Strategic TR US LCAP VA ETF | $4.7M | 134.4K | 0.6% | ▲New New position | |
| 39 | Schwab Strategic TR US MID-CAP ETF | $3.3M | 88.3K | 0.4% | ▲New New position | |
| 40 | Caesars Entertainment Inc Ne COM | $2.5M | 84.1K | 0.3% | ▼−91% Reduced · −808K sh | |
| 41 | Schwab Strategic TR US DIVIDEND EQ | $2.3M | 72.7K | 0.3% | ▲New New position | |
| 42 | Alphabet Inc CAP STK CL A | $1.4M | 4.0K | 0.2% | ▼−2.9% Reduced · −120 sh | |
| 43 | Schwab Strategic TR INTERNL DIVID | $1.4M | 43.2K | 0.2% | ▲New New position | |
| 44 | Texas Pacific Land Corporati COM | $1.4M | 3.1K | 0.2% | —Held | |
| 45 | Travelers Companies Inc COM | $1.1M | 3.3K | 0.1% | —Held | |
| 46 | Schwab Strategic TR US REIT ETF | $880K | 37.2K | 0.1% | ▲New New position | |
| 47 | Alphabet Inc CAP STK CL C | $840K | 2.4K | 0.1% | —Held | |
| 48 | Schwab Strategic TR 1 5YR CORP BD | $831K | 33.7K | 0.1% | ▲New New position | |
| 49 | Remitly Global Inc COM | $784K | 35.0K | 0.1% | ▲+40% Added · +10K sh | |
| 50 | Frequency Electrs Inc COM | $776K | 11.7K | 0.1% | —Held |
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1113629/holdings"
Use Arkolith to show VILLERE ST DENIS J & CO LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Aug 7, 2026 | 85 | $837.8M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 30, 2026 | 76 | $906.9M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 28, 2026 | 80 | $996.7M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 24, 2025 | 81 | $1.0B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 24, 2025 | 83 | $1.0B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 30, 2025 | 85 | $1.1B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 1, 2024 | 86 | $1.2B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.